Recent news and posts
Bi-weekly snapshot of market access and HEOR project work at MTRC – Edition 24th of August 2026
Our goal at MTRC is to inform the decision-making of our clients and to support their market access activities. Below is a snapshot of our planned activities for the next two weeks. This can help our existing and prospective clients understand the potential scope of our support better.
From the week of August 24th, we are planning to work on 11 projects, including:
Reimbursement
- Working on market access strategy for surgical treatment in the ophthalmology area in England, France, Italy, the Netherlands, Spain, Sweden, and Switzerland
- Working on reimbursement analysis for molecular diagnostic technologies in 12 European countries
- Working on analysis or coverage and reimbursement framework for point-of-care tests in England, Germany, Italy, the Netherlands, and Spain
- Working on market size analysis for diagnostic technology in the neurology area in Germany
- Working on the reimbursement analysis for minimally invasive treatment in the ophthalmology area in the Netherlands
HEOR
- Delivering validation of a health economic model in the cardiology area
- Delivering an adaptation of a health economic model for a cardiovascular technology in the Kingdom of Saudi Arabia healthcare setting
- Working on the development of a health economic model for in-vitro diagnostic tests in neurology disease areas in England, France, Germany, Italy, and Spain
- Working on a systematic literature review and meta-analysis for an in vitro diagnostic test
- Working on the development of a value dossier for a personalized blood test in the oncology area
- Working on the development of a value dossier for technology in the cardiovascular area
Let us know if you need any market access or HEOR support for your medical technology in Europe.